Company intelligence / Profile preview

Umeda Company

Ownership: Private
Development stage: Other

Overview

Umeda Seiyaku is a Japanese pharmaceutical company primarily focused on the manufacturing and distribution of active pharmaceutical ingredients (APIs) and finished dosage forms. The company operates as a contract manufacturing organization (CMO) and a developer of generic medications, specializing in high-quality production standards. Their business model centers on providing reliable supply chain solutions for the domestic Japanese market and international partners. Umeda Seiyaku maintains facilities capable of handling various chemical syntheses and pharmaceutical formulations.

Modalities: Small molecule
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Umeda Company.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Umeda Company.